"Diabetic Retinopathy" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Disease of the RETINA as a complication of DIABETES MELLITUS. It is characterized by the progressive microvascular complications, such as ANEURYSM, interretinal EDEMA, and intraocular PATHOLOGIC NEOVASCULARIZATION.
| Descriptor ID |
D003930
|
| MeSH Number(s) |
C11.768.257 C14.907.320.382 C19.246.099.500.382
|
| Concept/Terms |
Diabetic Retinopathy- Diabetic Retinopathy
- Diabetic Retinopathies
- Retinopathies, Diabetic
- Retinopathy, Diabetic
|
Below are MeSH descriptors whose meaning is more general than "Diabetic Retinopathy".
Below are MeSH descriptors whose meaning is more specific than "Diabetic Retinopathy".
This graph shows the total number of publications written about "Diabetic Retinopathy" by people in this website by year, and whether "Diabetic Retinopathy" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 |
| 1998 | 0 | 1 | 1 |
| 2001 | 1 | 0 | 1 |
| 2002 | 0 | 1 | 1 |
| 2005 | 1 | 0 | 1 |
| 2006 | 1 | 2 | 3 |
| 2007 | 1 | 0 | 1 |
| 2011 | 2 | 0 | 2 |
| 2013 | 1 | 0 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 2 | 0 | 2 |
| 2016 | 9 | 2 | 11 |
| 2017 | 9 | 1 | 10 |
| 2018 | 9 | 1 | 10 |
| 2019 | 19 | 0 | 19 |
| 2020 | 14 | 1 | 15 |
| 2021 | 15 | 0 | 15 |
| 2022 | 15 | 0 | 15 |
| 2023 | 16 | 0 | 16 |
| 2024 | 9 | 0 | 9 |
| 2025 | 4 | 0 | 4 |
To return to the timeline,
click here.
Below are the most recent publications written about "Diabetic Retinopathy" by people in Profiles.
-
IMPACT OF THE DEXAMETHASONE IMPLANT ON SLOWING DIABETIC RETINOPATHY PROGRESSION: Post Hoc Analysis of the MEAD Study. Retina. 2025 Dec 01; 45(12):2252-2262.
-
Anatomic biomarkers as potential endpoints in diabetic macular edema: A systematic literature review with identification of macular volume as a key surrogate for visual acuity. Surv Ophthalmol. 2025 Nov-Dec; 70(6):1090-1110.
-
Port Delivery System With Ranibizumab vs Monitoring in Nonproliferative Diabetic Retinopathy Without Macular Edema: The Pavilion Randomized Clinical Trial. JAMA Ophthalmol. 2025 Apr 01; 143(4):317-325.
-
Evaluation of macular retinal oximetry across different levels of diabetic retinopathy: a cross sectional study. BMC Ophthalmol. 2025 Jan 17; 25(1):24.
-
Glucagon-like Peptide-1 Receptor Agonists in the Management of Diabetic Retinopathy. Int Ophthalmol Clin. 2025 Jan 01; 65(1):23-26.
-
Follow-up Adherence After Teleretinal Screening for Diabetic Retinopathy. Int Ophthalmol Clin. 2025 Jan 01; 65(1):35-39.
-
Comparing Teleretinal Screening-Identified Diabetic Retinopathy With Diabetic Nephropathy and Other Markers of Systemic Disease. Int Ophthalmol Clin. 2025 Jan 01; 65(1):27-33.
-
Influence of Common Medications on Diabetic Macular Edema in Type 2 Diabetes Mellitus. Ophthalmol Retina. 2025 Jun; 9(6):505-514.
-
Total retinal thickness is an important factor in evaluating diabetic retinal neurodegeneration. BMJ Open Ophthalmol. 2024 Nov 07; 9(1).
-
SUPPLEMENTAL DEXTROSE IN THE INFUSION FLUID DURING DIABETIC VITRECTOMY. Retina. 2024 11 01; 44(11):1931-1936.